These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 6707194

  • 21. A case of acromegaly associated with Graves' disease. A possible role of endogenous TRH and an effect of bromocriptine on GH and TSH secretion.
    Demura R, Demura H, Odagiri E, Shizume K.
    Endocrinol Jpn; 1984 Dec; 31(6):801-7. PubMed ID: 6442699
    [Abstract] [Full Text] [Related]

  • 22. Hyperthyroidism due to a pituitary adenoma composed of two different cell types, one secreting alpha-subunit alone and another cosecreting alpha-subunit and thyrotropin.
    Terzolo M, Orlandi F, Bassetti M, Medri G, Paccotti D, Cortelazzi D, Angeli A, Beck-Peccoz P.
    J Clin Endocrinol Metab; 1991 Feb; 72(2):415-21. PubMed ID: 1704010
    [Abstract] [Full Text] [Related]

  • 23. Hyperthyroidism due to inappropriate secretion of thyroid-stimulating hormone: diagnosis and management.
    Hermus A, Ross H, van Liessum P, Naber A, Smals A, Kloppenborg P.
    Neth J Med; 1991 Jun; 38(5-6):193-8. PubMed ID: 1922591
    [Abstract] [Full Text] [Related]

  • 24. Bromocriptine and Triac therapy for hyperthyroidism due to pituitary resistance to thyroid hormone.
    Dulgeroff AJ, Geffner ME, Koyal SN, Wong M, Hershman JM.
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1071-5. PubMed ID: 1400873
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The late effects of neonatal hyperthyroidism upon the feedback regulation of TSH secretion in rats.
    Bakke JL, Lawrence NL, Bennett J, Robinson S.
    Endocrinology; 1975 Sep; 97(3):659-64. PubMed ID: 809256
    [Abstract] [Full Text] [Related]

  • 29. [Hyperthyroidism caused by non-neoplastic inappropriate TSH secretion].
    Agapito A, Guerra L, Afonso A, Fonseca F, Malheiro F, da Costa C.
    Acta Med Port; 1992 Feb; 5(2):104-6. PubMed ID: 1595367
    [Abstract] [Full Text] [Related]

  • 30. [Hypophyseal hyperthyroidism. Non-tumoral hypersecretion of thyroid stimulating hormone with clinical hyperthyroidism].
    Bregengård C, Eigtved AI, Siersbaek-Nielsen K.
    Ugeskr Laeger; 1989 Dec 11; 151(50):3404-5. PubMed ID: 2609451
    [Abstract] [Full Text] [Related]

  • 31. The effect of glucocorticoid administration on human pituitary secretion of thyrotropin and prolactin.
    Re RN, Kourides IA, Ridgway EC, Weintraub BD, Maloof F.
    J Clin Endocrinol Metab; 1976 Aug 11; 43(2):338-46. PubMed ID: 820709
    [Abstract] [Full Text] [Related]

  • 32. Dissociation of responsiveness to thyrotropin-releasing hormone and thyroid suppressibility following antithyroid drug therapy of hyperthyroidism.
    Martino E, Pinchera A, Capiferri R, Macchia E, Sardano G, Bartalena L, Mazzanti F, Baschieri L.
    J Clin Endocrinol Metab; 1976 Sep 11; 43(3):543-9. PubMed ID: 821960
    [Abstract] [Full Text] [Related]

  • 33. Endocrine, biochemical, and morphological studies of a pituitary adenoma secreting growth hormone, thyrotropin (TSH), and alpha-subunit: evidence for secretion of TSH with increased bioactivity.
    Beck-Peccoz P, Piscitelli G, Amr S, Ballabio M, Bassetti M, Giannattasio G, Spada A, Nissim M, Weintraub BD, Faglia G.
    J Clin Endocrinol Metab; 1986 Apr 11; 62(4):704-11. PubMed ID: 2419356
    [Abstract] [Full Text] [Related]

  • 34. Severe hyperthyroidism due to neoplastic TSH hypersecretion in an old man.
    Rubello D, Busnardo B, Girelli ME, Piccolo M.
    J Endocrinol Invest; 1989 Sep 11; 12(8):571-5. PubMed ID: 2592743
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Bioactivity of thyrotropin (TSH) in patients with central hypothyroidism: comparison between in vivo 3,5,3'-triiodothyronine response to TSH and in vitro bioactivity of TSH.
    Horimoto M, Nishikawa M, Ishihara T, Yoshikawa N, Yoshimura M, Inada M.
    J Clin Endocrinol Metab; 1995 Apr 11; 80(4):1124-8. PubMed ID: 7714080
    [Abstract] [Full Text] [Related]

  • 37. Thyrotropin secretion in patients with central hypothyroidism: evidence for reduced biological activity of immunoreactive thyrotropin.
    Faglia G, Bitensky L, Pinchera A, Ferrari C, Paracchi A, Beck-Peccoz P, Ambrosi B, Spada A.
    J Clin Endocrinol Metab; 1979 Jun 11; 48(6):989-98. PubMed ID: 109460
    [Abstract] [Full Text] [Related]

  • 38. 3,5,3'-triiodothyroacetic acid therapy for thyroid hormone resistance.
    Kunitake JM, Hartman N, Henson LC, Lieberman J, Williams DE, Wong M, Hershman JM.
    J Clin Endocrinol Metab; 1989 Aug 11; 69(2):461-6. PubMed ID: 2753985
    [Abstract] [Full Text] [Related]

  • 39. Absence of receptors for thyrotropin (TSH)-releasing hormone in human TSH-secreting pituitary adenomas associated with hyperthyroidism.
    Chanson P, Li JY, Le Dafniet M, Derome P, Kujas M, Murat A, Charpentier G, Racadot J, Peillon F.
    J Clin Endocrinol Metab; 1988 Feb 11; 66(2):447-50. PubMed ID: 2828411
    [Abstract] [Full Text] [Related]

  • 40. TSH secretion and regulation in endemic goiter and endemic cretinism.
    Medeiros-Neto G.
    Prog Clin Biol Res; 1983 Feb 11; 116():119-30. PubMed ID: 6304776
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.